Assays
What is an Assay?Filters
Western blot
Submitter: Olga Krebs
Assay type: Immune Precipitation
Technology type: Technology Type
Investigation: LiSyM-Cancer project data for integration into...
Experimental assay Human-NAFLD/eNASH Samples for the eNASH category were obtained in patients undergoing bariatric surgery with a BMI > 30 and subgroups defined by liver histology as follows: eNASH samples were characterized by >5% fat, an inflammation grade of at least 1, fibrosis ≤1 and ballooning ≤1.
Image data for this assay available via link to file folder containing image data for listed patient IDs (patientID in a file name) ...
Submitter: Olga Krebs
Assay type: Experimental Assay Type
Technology type: Technology Type
Investigation: Three-dimensional spatially resolved geometrica...
Experimental assay Human-NAFLD/STEA 8 biopsies from steatosis patients. Samples for the STEA category were obtained in patients undergoing bariatric surgery with a BMI > 30 and subgroups defined by liver histology as follows: STEA samples had >5% fat, no inflammation, fibrosis ≤1 and ballooning ≤1.
Image data for this assay available via link to file folder containing image data for listed patient IDs (patientID in a file name)
...
Submitter: Fabian Segovia Miranda
Assay type: Experimental Assay Type
Technology type: Technology Type
Investigation: Three-dimensional spatially resolved geometrica...
Experimental assay Human-NAFLD/NC 6 biopsies from normal control patients. : NC samples showed steatosis ≤5%, no inflammation, no ballooning and no fibrosis and were obtained during liver resections or biopsy in non-hepatobiliary malignancy in patients with a BMI<30kg/m2. Livers were either free of metastases or a distance of at least 2 cm to the next metastasis observed.
Image data for this assay available via link to file folder containing ...
Submitter: Fabian Segovia Miranda
Assay type: Image Collection
Technology type: Technology Type
Investigation: Three-dimensional spatially resolved geometrica...
Experimental assay Human-NAFLD/HO , 4 biopsies from healthy obese patients. Samples for the HO category were obtained in patients undergoing bariatric surgery with a BMI > 30 and subgroups defined by liver histology as follows: HO samples showed a normal liver histology such as the NC samples.
-h692a -h6758 -h6922 -h7230
Files can be opened and visualised with http://motiontracking.mpi-cbg.de/get/ software
Submitter: Fabian Segovia Miranda
Assay type: Experimental Assay Type
Technology type: Technology Type
Investigation: Three-dimensional spatially resolved geometrica...
The liver comprises the body´s largest pool of macrophages constituting approximately 80 % of all sessile tissue macrophages of the body. After liver damage monocyte-derived macrophages are recruited into the liver and were here affected by a micro milieu which is considerably influenced by hepatocytes. Up to now the complex network that determines the differentiation and function of liver macrophages and the impact of the intercellular communication between macrophages and the other parenchymal ...
Submitter: Stephanie Wolf
Assay type: Shotgun proteomics
Technology type: LTQ Orbitrap Elite
Investigation: Hepatocytes reprogram liver macrophages involvi...
We describe a distinct macrophage population, whose presence in the liver during homoeostasis depends on recruitment signals mediated by the chemokine receptor CCR2. The identified polarization state of this population closely resembles that induced in co-culture experiments, where hepatocytes are reducing the availability of TGFb to macrophages. Accordingly, disruption of TGFb signal transduction in macrophages phenocopies the influence of hepatocytes on macrophage polarization.
Submitter: Stephanie Wolf
Assay type: Transcriptomics
Technology type: Technology Type
Investigation: Hepatocytes reprogram liver macrophages involvi...
Transcriptomics: the RNA expression of primary hepatocytes and BMDM (Bone Marrow–Derived acrophages) were analysed in 4 different conditions (mono- vs. co-culture, hepatocytes and macrophages) with 5 replicas each to detect the impact of hepatocytes on macrophages and vice versa.
Submitter: Stephanie Wolf
Assay type: Experimental Assay Type
Technology type: Technology Type
Investigation: Hepatocytes reprogram liver macrophages involvi...
RNA sequence data
Submitter: Olga Krebs
Assay type: RNA-seq Profiling
Technology type: Technology Type
Investigation: LiSyM-Cancer project data for integration into...
Study: GENOMICS/TRANSCRIPTOMICS
DNA sequence data
Submitter: Olga Krebs
Assay type: Transcriptomics
Technology type: Technology Type
Investigation: LiSyM-Cancer project data for integration into...
Study: GENOMICS/TRANSCRIPTOMICS
Submitter: Olga Krebs
Biological problem addressed: Signal Induction
Investigation: Investigation of the Smad Protein Complex Forma...
exp assay I Lucarelli paper
Submitter: Olga Krebs
Assay type: Proteomics
Technology type: Mass Spectrometry
Investigation: Investigation of the Smad Protein Complex Forma...
DMPlaning 2022
Submitter: Olga Krebs
Biological problem addressed: Model Analysis Type
Investigation: 1 hidden item
Study: 1 hidden item
Transcriptomic analysis of hepatocytes captured by laser micro-dissection from hepatic zone: periportal (PP)
Submitter: Mario Brosch
Assay type: RNA-seq Profiling
Technology type: Rna-seq
Investigation: Epigenomic analysis of micro-dissected human liver
Transcriptomic analysis of hepatocytes captured by laser micro-dissection from hepatic zone: intermediate (IZ)
Submitter: Mario Brosch
Assay type: RNA-seq Profiling
Technology type: Rna-seq
Investigation: Epigenomic analysis of micro-dissected human liver